Michael Kolodziej, MD

Breaking Down Health Care

The Balance Between Drug Safety and Availability

06/17/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the process of drug approvals and the role of the US Food and Drug Administration, including how and why the process takes so much time—and...

In this Breaking Down Health...

06/17/2024

Cancer Care Business Exchange

CBEx HIGHLIGHT

The Bear: Why Does Health Care Cost So Much? (Part 1)

06/03/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these entities contribute to...

In this Breaking Down Health...

06/03/2024

Journal of Clinical Pathways

Breaking Down Health Care

Medicare for All: Careful What You Wish for

06/03/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of Medicare for All and universal health care: why these terms are not interchangeable, and if they could actually solve the...

In this Breaking Down Health...

06/03/2024

Cancer Care Business Exchange

Breaking Down Health Care

The Bear: Why Does Health Care Cost So Much? (Part 2)

05/20/2024

Michael Kolodziej, MD

John Hennessy, MBA

In part two of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into the other main stakeholders in health care costs: pharmaceutical manufacturers and providers. They discuss how these...

In part two of this two-part...

05/20/2024

Cancer Care Business Exchange

Perspectives

The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study

03/16/2020

Andrew Hertler, MD, FACP

William A Flood, MD, MS

Ray Page, DO, PhD, FACOI, FASCO

Barry Brooks, MD

Steve L D’Amato, BSPharm, BCOP

Michael Kolodziej, MD

Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...

...

03/16/2020

Journal of Clinical Pathways